FDAnews Drug Daily Bulletin

J&J Appoints Gorsky CEO as Company Seeks Stability After Recall Concerns

Feb. 23, 2012
A A
Johnson & Johnson (JNJ)’s insider pick of Alex Gorsky as the new chief executive officer elevates the person most familiar with the safety and quality issues that have plagued the company.
Bloomberg